Policy
EU recommendations for 2026/2027 seasonal flu vaccine composition
EMA ·
The Brief
- The European Medicines Agency published EU recommendations for the 2026/2027 seasonal flu vaccine composition.
- The recommendations were updated on 17 November 2026 to include a recommendation for mRNA (nucleic acid) influenza vaccines.
- The source gives no further detail on the specific strains or composition, which are set out in an annex not included in the excerpt.
Why it matters
The update extends EU composition guidance for seasonal influenza vaccines to mRNA-based vaccines, which bears on how future flu vaccines are developed and approved.
Who’s affected
- vaccine developers and manufacturers
- public health authorities and healthcare providers
- 2026/2027 seasonal flu vaccine composition recommendations
- #influenza
- #vaccines
- #mrna
- #eu-regulation
- #public-health
The recommendations were updated and published on the following dates: 17 November 2026: to include a recommendation for mRNA (nucleic acid) influenza vaccines. Annex I…